Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034033 · ClinicalTrials.gov registry record
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
A clinical trial of Breast Cancer and Ovarian Cancer, sponsored by Stanford University.
- Recruiting
- Registry status
- 3,300
- Enrollment target
- 1
- Study location
NCT01034033 is a study of Breast Cancer and Ovarian Cancer that is actively recruiting participants, run by Stanford University. The registered enrollment target is 3,300 participants, above the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01034033, a study of Breast Cancer and Ovarian Cancer, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 3,300 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.
Conditions Studied
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,300 participants |
| Start Date | 2001-08 |
| Est. Completion | 2099-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034033
The ClinicalTrials.gov registry entry for NCT01034033 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 3,300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (18% higher). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01034033 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01034033 about?
NCT01034033 is a clinical study titled "Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples". The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be stu...
What is the current status of trial NCT01034033?
This trial is currently recruiting. The enrollment target is 3,300 participants. The study started on 2001-08. Estimated completion is 2099-01.
What conditions does trial NCT01034033 study?
This clinical trial studies the following conditions: Breast Cancer, Ovarian Cancer, Gynecologic Cancers, Ovarian/Peritoneal/Fallopian Cancer.
Who is sponsoring clinical trial NCT01034033?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01034033 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.